Therapeutic Targets Database
BIDD Pharmainformatics Databases


TTD Drug ID: DCL000511

Drug Information
CompanyRoche & Genentech
IndicationLymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin
[ICD9: 202.8   ICD10: C81-C96]
Discontinued    [1]

Click to save drug structure in 3D MOL format

Click to save drug structure in 2D MOL format
Canonical SMILESC1CC1CN2CCC34C5C6=C(CC3(C2CC7=C4C(=C(C=C7)O)O5)O)C8=CC=CC=C8N6.O.Cl    
Isomeric SMILESC1CC1CN2CC[C@]34[C@@H]5C6=C(C[C@]3(C2CC7=C4C(=C(C=C7)O)O5)O)C8=CC=CC=
CAS NumberCAS 880486-59-9
PubChem Compound IDCID 23581811.
TargetB-cell surface antigen CD40Antibody[2][3]
Ref 1New developments in immunosuppressive therapy for heart transplantation. Expert Opin Emerg Drugs. 2009 Mar;14(1):1-21. To Reference
Ref 2Roche. Product Development Pipeline. July 29 2009. To Reference
Ref 32011 Pipeline of Seattle Genetics. To Reference


Welcome to sign our Guestbook.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhu.

Dr. Chen Yuzong
Deputy Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore

All rights reserved.

Computer-aided Drug Design
about BIDD |  databases |  software |  teaching |  research |  links


Department of Computational Science | National University of Singapore | Blk S17, 3 Science Drive 2, Singapore 117543